Tocotrienols In Solid Dosage Form

The bioavailability study of Tocomax® 20% powder containing mixed tocotrienols was carried out using Sprague-Dawley rats. The study showed that Tocomax® 20% powder had comparative oral bioavailability as the Tocovid® Suprabio (1.0, 1.0 and 1.2 times for alpha, gamma and delta tocotrienols respective...

Full description

Bibliographic Details
Main Author: Cheah, Mei Mei
Format: Thesis
Language:English
Published: 2014
Subjects:
Online Access:http://eprints.usm.my/46068/
http://eprints.usm.my/46068/1/Cheah%20Mei%20Mei24.pdf
_version_ 1848880504579817472
author Cheah, Mei Mei
author_facet Cheah, Mei Mei
author_sort Cheah, Mei Mei
building USM Institutional Repository
collection Online Access
description The bioavailability study of Tocomax® 20% powder containing mixed tocotrienols was carried out using Sprague-Dawley rats. The study showed that Tocomax® 20% powder had comparative oral bioavailability as the Tocovid® Suprabio (1.0, 1.0 and 1.2 times for alpha, gamma and delta tocotrienols respectively). In addition, it was also found to have better oral bioavailability as compared to Tocomin® 50% oily formulation (1.9, 2.4 and 2.9 times for alpha, gamma and delta tocotrienol respectively). Subsequent usage of Tocomax® 20% powder as the active ingredient for the formulation of tablets containing tocotrienols showed that a satisfactory tablet could be obtained using Neusilin UFL2 and US2 as the diluent, Ac-Di-Sol as the disintegrant and magnesium stearate as the lubricant with the ideal tablet weight of 500 mg per tablet. The tablets were homogeneous in colour and with no physical defects like capping. The tablets also have good disintegration times of approximately 8 minutes and were uniform in weight (less than 2%). The tablets with the optimized formulation were also successfully up-scaled.
first_indexed 2025-11-15T18:04:11Z
format Thesis
id usm-46068
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:04:11Z
publishDate 2014
recordtype eprints
repository_type Digital Repository
spelling usm-460682020-02-03T04:13:21Z http://eprints.usm.my/46068/ Tocotrienols In Solid Dosage Form Cheah, Mei Mei RS1-441 Pharmacy and materia medica The bioavailability study of Tocomax® 20% powder containing mixed tocotrienols was carried out using Sprague-Dawley rats. The study showed that Tocomax® 20% powder had comparative oral bioavailability as the Tocovid® Suprabio (1.0, 1.0 and 1.2 times for alpha, gamma and delta tocotrienols respectively). In addition, it was also found to have better oral bioavailability as compared to Tocomin® 50% oily formulation (1.9, 2.4 and 2.9 times for alpha, gamma and delta tocotrienol respectively). Subsequent usage of Tocomax® 20% powder as the active ingredient for the formulation of tablets containing tocotrienols showed that a satisfactory tablet could be obtained using Neusilin UFL2 and US2 as the diluent, Ac-Di-Sol as the disintegrant and magnesium stearate as the lubricant with the ideal tablet weight of 500 mg per tablet. The tablets were homogeneous in colour and with no physical defects like capping. The tablets also have good disintegration times of approximately 8 minutes and were uniform in weight (less than 2%). The tablets with the optimized formulation were also successfully up-scaled. 2014-01 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/46068/1/Cheah%20Mei%20Mei24.pdf Cheah, Mei Mei (2014) Tocotrienols In Solid Dosage Form. Masters thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Cheah, Mei Mei
Tocotrienols In Solid Dosage Form
title Tocotrienols In Solid Dosage Form
title_full Tocotrienols In Solid Dosage Form
title_fullStr Tocotrienols In Solid Dosage Form
title_full_unstemmed Tocotrienols In Solid Dosage Form
title_short Tocotrienols In Solid Dosage Form
title_sort tocotrienols in solid dosage form
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/46068/
http://eprints.usm.my/46068/1/Cheah%20Mei%20Mei24.pdf